Quantcast
Home / Courts / Novartis hit with nearly $13M verdict in failure-to-warn case (access required)

Novartis hit with nearly $13M verdict in failure-to-warn case (access required)

A federal jury in Winston-Salem has returned a verdict of nearly $13 million against pharmaceutical giant Novartis, saying the company failed to adequately warn patients and doctors about the risks of taking the bone-strengthening drugs Zometa and Aredia. The estate of Rita Fussman of Chapel Hill had sued Novartis after Fussman came down with what at first appeared to be a mysterious jaw disease after she had been taking the drugs for several years. Fussman discovered her complications with the drug when she had a CT scan on her jaw. "The guy said, ‘You have exposed bone in your mouth,'" said Vernon Glenn (pictured) of Winston-Salem, a second-chair attorney for Fussman.

Leave a Reply

Your email address will not be published. Required fields are marked *

*